T0	Participants 65 143	bleeding or blood product requirements associated with cardiopulmonary bypass.
T1	Participants 507 569	92 patients with overt bleeding and a prolonged bleeding time.
T2	Participants 1565 1622	patients with excessive immediate postoperative bleeding.